Revisiting clinicomycological and immunological aspects of fungal rhinosinusitis during COVID-19 pandemic

FRS is an important emerging public health problem and a cause of mortality and morbidity, particularly in immunocompromised patients. Furthermore, in the current scenario of the COVID pandemic, FRS has become more fatal and an entity of immediate and grave concern than ever before. Early identification in suspected cases with predisposing factors and early intervention is crucial for the outcome of FRS cases.